Azabicycloalkyl derivatives, a process for their preparation and pharmaceutical compositions containing them
申请人:BEECHAM GROUP PLC
公开号:EP0013138A1
公开(公告)日:1980-07-09
A compound of the formula (I), and pharmaceutically acceptable salts thereof:
wherein:
R1 is a C1-6 alkoxy group;
R2 and R3 are the same or different and are hydrogen, halogen, CF3, C2-7 acyl, C2-7 acylamino, or amino, aminocarbonyl or aminosulphone optionally substituted by one or two C1-6 alkyl groups, C1-6 alkylsulphone or nitro;
R5 is hydrogen or Ci-e alkyl;
R6 is C1-7 alkyl or a group -(CH2)5R7 where s is 0 to 2 and R, is a C3-8 cycloalkyl group, or a group -(CH2)tR5 where t is 1 or 2 and R8 is C2-5 alkenyl or a phenyl group optionally substituted by one or two substituents selected from C1-6 alkyl, C1-4 alkoxy, trifluoromethyl and halogen; and
n, p and q are independently 0 to 2; have useful pharmacological activity.
式 (I) 的化合物及其药学上可接受的盐类:
其中
R1 是 C1-6 烷氧基;
R2 和 R3 相同或不同,并且是氢、卤素、CF3、C2-7 乙酰基、C2-7 乙酰氨基或任选被一个或两个 C1-6 烷基、C1-6 烷基砜或硝基取代的氨基、氨基羰基或氨基砜;
R5 是氢或 Ci-e 烷基;
R6 是 C1-7 烷基或基团-(CH2)5R7(其中 s 是 0 至 2),R 是 C3-8 环烷基,或基团-(CH2)tR5(其中 t 是 1 或 2),R8 是 C2-5 烯基或苯基,可选择被一个或两个选自 C1-6 烷基、C1-4 烷氧基、三氟甲基和卤素的取代基取代;以及
n、p 和 q 独立地为 0 至 2;具有有用的药理活性。